APOB and congenital bilateral aplasia of vas deferens from CFTR mutation: In addition, combining multiomics studies to explore the specific signaling pathways and key factors involved in the APOB/APOA1 affecting valve calcification will help to investigate therapeutic agents targeting these pathways and key factors, thereby slowing down the progression of CAVD.